SXTP
60 DEGREES PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.96
−3.69%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.61
- Revenue estimate
- $270.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.90
- EPS estimate
- -$0.74
- Revenue actual
- $210.0K
- Revenue estimate
- $185.8K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 9
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -36.5%
- Revenue beats (12Q)
- 4
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.74 | -$0.90 | Miss -21.62% | $210.0K |
| May 15, 2026 | -$0.76 | -$1.28 | Miss -68.42% | $162.1K |
| Mar 26, 2026 | -$2.28 | -$2.56 | Miss -12.28% | $670.0K |
| Nov 13, 2025 | -$1.84 | -$2.64 | Miss -43.48% | $437.6K |
| Aug 13, 2025 | -$1.24 | -$1.25 | Miss -0.81% | $100.9K |
| May 15, 2025 | -$1.31 | -$1.56 | Miss -19.08% | $163.6K |
| Mar 27, 2025 | -$4.01 | -$14 | Miss -254.11% | $261.4K |
| Nov 14, 2024 | -$3.00 | -$4.65 | Miss -55.00% | $135.3K |
| Aug 14, 2024 | -$20 | -$21 | Miss -6.82% | $125.0K |
| May 15, 2024 | -$9.60 | $1.80 | Beat 118.75% | $105.7K |
| Nov 20, 2023 | -$16 | -$18 | Miss -15.37% | $51.2K |
| Aug 25, 2023 | — | -$1.40 | — | $59.5K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026